Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Author response: Does the time of inactivation of pRb determine the cell of origin of retinoblastoma?

Corson TW, Pajovic S, Dimaras H, Thériault BL, Gallie BL.

Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):676. doi: 10.1167/iovs.11-9371. No abstract available.

PMID:
22331504
2.

Does the time of inactivation of pRb determine the cell of origin of retinoblastoma?

Madhavan J, Khetan V.

Invest Ophthalmol Vis Sci. 2011 Dec 9;52(13):9403. doi: 10.1167/iovs.11-8843. No abstract available.

PMID:
22159398
3.

The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.

Pajovic S, Corson TW, Spencer C, Dimaras H, Orlic-Milacic M, Marchong MN, To KH, Thériault B, Auspitz M, Gallie BL.

Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7618-24. doi: 10.1167/iovs.11-7989.

4.

Cancer stem cell characteristics in retinoblastoma.

Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F.

Mol Vis. 2005 Sep 12;11:729-37.

5.

Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.

Deepa PR, Vandhana S, Jayanthi U, Krishnakumar S.

Basic Clin Pharmacol Toxicol. 2012 Jun;110(6):494-503. doi: 10.1111/j.1742-7843.2011.00844.x. Epub 2012 Jan 16.

6.

Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.

Dimaras H, Coburn B, Pajovic S, Gallie BL.

Mol Carcinog. 2006 May;45(5):333-43.

PMID:
16555252
7.

Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.

Orjuela M, Orlow I, Dudas M, Ponce-Castañeda MV, Ridaura C, Leal C, Salazar A, Abramson D, Gerald W, Cordon-Cardo C.

Hum Pathol. 2001 May;32(5):537-44.

PMID:
11381373
8.

Multiple genetic loci modify risk for retinoblastoma in transgenic mice.

Griep AE, Krawcek J, Lee D, Liem A, Albert DM, Carabeo R, Drinkwater N, McCall M, Sattler C, Lasudry JG, Lambert PF.

Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2723-32.

PMID:
9856783
9.

The search for the retinoblastoma cell of origin.

Dyer MA, Bremner R.

Nat Rev Cancer. 2005 Feb;5(2):91-101. Review.

PMID:
15685194
10.

Retinoblastoma protein in microphthalmic mice.

Richter J, Brylla E, Lenk C, Ernstberger J, Hilbig H.

Exp Toxicol Pathol. 2000 Mar;52(1):17-22.

PMID:
10779148
11.

Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Coupland SE, Bechrakis N, Schüler A, Anagnostopoulos I, Hummel M, Bornfeld N, Stein H.

Br J Ophthalmol. 1998 Aug;82(8):961-70.

12.

Retinoblastoma: animal models.

Conway RM, Wheeler SM, Murray TG, Jockovich ME, O'Brien JM.

Ophthalmol Clin North Am. 2005 Mar;18(1):25-39, vii. Review.

PMID:
15763189
13.

Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.

Tsui JY, Dalgard C, Van Quill KR, Lee L, Grossniklaus HE, Edelhauser HF, O'Brien JM.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):490-6. doi: 10.1167/iovs.07-0653.

PMID:
18234990
14.

Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.

Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM Jr, Grossniklaus HE, Edelhauser HF, O'Brien JM.

Ophthalmology. 2005 Jun;112(6):1151-8.

PMID:
15885791
15.

Retinoblastoma teaches a new lesson.

te Riele H.

Cell. 2007 Oct 19;131(2):227-9.

16.

Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Larose A, Dyson N, Sullivan M, Harlow E, Bastin M.

J Virol. 1991 May;65(5):2308-13.

17.

Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.

Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):679-85. doi: 10.1167/iovs.09-4073. Epub 2009 Sep 8.

PMID:
19737884
18.

Retinoblastoma: from disease to discovery.

Madhavan J, Ganesh A, Kumaramanickavel G.

Ophthalmic Res. 2008;40(5):221-6. doi: 10.1159/000128578. Epub 2008 Apr 29. Review.

PMID:
18446017
19.

Developmental defects and tumor predisposition in Rb mutant mice.

Vooijs M, Berns A.

Oncogene. 1999 Sep 20;18(38):5293-303. Review.

20.

On neuronal and glial differentiation of a pluripotent stem cell line, RT4-AC: a branch determination.

Sueoka N, Droms K.

Curr Top Dev Biol. 1986;20:211-21. Review. No abstract available.

PMID:
3007033

Supplemental Content

Support Center